Innoviva Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | Outperform |
2
|
$131.19 | $130.51 | 9.00% | 11 | $332.28B |
| ABT | Abbott Laboratories | Outperform |
9
|
$104.09 | $118.92 | 21.53% | 7 | $181.08B |
| PFE | Pfizer | Outperform |
2
|
$28.64 | $32.87 | 6.49% | 6 | $162.29B |